People · Operator
Named in public records as an officer, director or promoter · active 2015–2026 · Biotechnology, Pharmaceuticals, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Lycia Therapeutics, Inc. | — | Biotechnology | Series D+ | $202.0M | $1.2B | 2021 |
| Lenz Therapeutics, Inc. | — | Biotechnology | Series C | $136.2M | $1.2B | 2020 |
| Lycia Therapeutics, Inc. | Director | Biotechnology | Series C | $75.0M | $314.3M | 2026 |
| 858 Therapeutics, Inc. | — | Pharmaceuticals | Series B | $65.2M | $177.2M | 2021 |
| Mistral Therapeutics, Inc. | — | Biotechnology | Series B | $36.4M | $1.0B | 2018 |
| March Therapeutics, Inc. | — | Pharma | Series B | $23.0M | $289.6M | 2022 |
| Inception IBD, Inc. | — | Pharmaceuticals | Series A | $6.9M | $214.3M | 2015 |
| Jengu Therapeutics, Inc. | — | Biotechnology | Series A | $5.0M | $164.9M | 2020 |
Clare Ozawa at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Clare Ozawa on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Thomas Woiwode | 3 | 7 |
| Jerel Davis | 2 | 13 |
| BRADLEY BOLZON | 2 | 10 |
| Petpiboon Prasit | 2 | 7 |
| Bradley J. Bolzon | 2 | 5 |
| Jeremy Caldwell | 2 | 4 |
| Ming Fang | 2 | 4 |
| William Rieflin | 2 | 4 |
| Laurent Fischer | 2 | 4 |
| TIM ANDERSON | 2 | 3 |
| Aetna Wun Trombley | 2 | 3 |
| Ali Behbahani | 1 | 17 |
| Carlo Rizzuto | 1 | 7 |
| Mark - Lester | 1 | 6 |
| Zach Scheiner | 1 | 6 |
| Stefan Larson | 1 | 4 |
| THOMAS A COLL | 1 | 4 |
| Jeong Seuk Kang | 1 | 4 |
| James McCollum | 1 | 3 |
| CHRIS DIMITROPOULOS | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.